.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Dow
Covington
McKinsey
Healthtrust
AstraZeneca
Argus Health
Merck
Mallinckrodt
Chubb

Generated: November 22, 2017

DrugPatentWatch Database Preview

Merck Kgaa Company Profile

« Back to Dashboard

What is the competitive landscape for MERCK KGAA, and what generic and branded alternatives to MERCK KGAA drugs are available?

MERCK KGAA has two approved drugs.



Summary for Merck Kgaa

US Patents:0
Tradenames:2
Ingredients:1
NDAs:2
Drug Master File Entries: 18
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-010Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-009Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-006Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-008Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-002Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
NOVOTHYROX
levothyroxine sodium
TABLET;ORAL021292-008May 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
NOVOTHYROX
levothyroxine sodium
TABLET;ORAL021292-011May 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
LEVOTHYROXINE SODIUM
levothyroxine sodium
TABLET;ORAL076752-003Jun 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
NOVOTHYROX
levothyroxine sodium
TABLET;ORAL021292-010May 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Kgaa
NOVOTHYROX
levothyroxine sodium
TABLET;ORAL021292-005May 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MERCK KGAA drugs

Drugname Dosage Strength Tradename Submissiondate
levothyroxine sodium
for Injection200 mcg/vial
LEVOTHYROXINE SODIUM
5/1/2015
levothyroxine sodium
for Injection100 mcg/vial and 500 mcg/vial
LEVOTHYROXINE SODIUM
4/14/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Deloitte
Fish and Richardson
Moodys
Accenture
Novartis
Express Scripts
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot